Teva Pharmaceutical Industries Ltd (TEVA)

10.18 +1.26  +14.13% NYSE Jul 28, 13:22 USD
View Full Chart
Price Chart
View All TEVA News

News

View All Events

Events

Date Type Description
07/28/2021 Earnings Results Q2 2021 Earnings Results
07/28/2021 08:00 EST Earnings Calls Q2 2021 Earnings Call
06/14/2021 09:30 EST AGM 2021 Annual General Meeting
04/28/2021 Earnings Results Q1 2021 Earnings Results
04/28/2021 08:00 EST Earnings Calls Q1 2021 Earnings Call
02/10/2021 Earnings Results Q4 2020 Earnings Results
02/10/2021 08:00 EST Earnings Calls Q4 2020 Earnings Call
11/05/2020 Earnings Results Q3 2020 Earnings Results
11/05/2020 08:00 EST Earnings Calls Q3 2020 Earnings Call
08/05/2020 08:00 EST Earnings Calls Q2 2020 Earnings Call
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Headquartered in Israel, Teva Pharmaceutical is the largest generic drug manufacturer in the world. The company was formed in 1901 and has a portfolio of more than 3,500 medicines--roughly 1 out of 9 generic prescriptions in the U.S. is filled with a Teva product. The company also develops branded pharmaceuticals in the central nervous system, oncology, and respiratory categories. Teva's generic drug sales represent slightly over half of total revenue, with branded drug and distribution revenue making up the balance. Teva is an aggressive filer to bring generic drugs to market when brand patents expire and has the most generic products pending Food and Drug Administration approval.
  • URL: https://www.tevapharm.com
  • Investor Relations URL: https://ir.tevapharm.com/
  • HQ State/Province: N/A
  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Equity Style: Mid Cap/Value
  • Next Earnings Release: Jul. 28, 2021
  • Last Earnings Release: Jul. 28, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: Nov. 27, 2017

Top Fund Holders

Symbol Name Weighting
EIS iShares MSCI Israel ETF 5.10%
ISRA VanEck Vectors Israel ETF 3.92%
BMPEX Beck, Mack & Oliver Partners 3.88%
PPH VanEck Vectors Pharmaceutical ETF 3.14%
MVISX Miller Opportunity IS 2.68%
CCM8341 IA Clarington Global Opportunities FX (USD) 2.52%
MKIEX McKee International Equity Instl 2.14%
MFCCX Meridian Contrarian C 1.73%
PPYPX PIMCO RAE International I-2 0.94%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.